Pricing
Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 – an innovative first-in-class humanized anti-CCR7 antibody.
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (0)
Unverified
This company has no org chart yet
This company has no teams yet
This company has no offices yet